Open original FDA record ↗Recall record
- FDA identifier
- Z-0048-2018
- Company in FDA record
- W L Gore & Associates, Inc.
- FDA classification date
- Oct 25, 2017
- First observed by MedTech Watch
- Nov 16, 2026
- Latest observed content change
- Nov 16, 2026
- Recall classification
- Class II
Reason stated in the source
Incomplete and/or partial deployment of the CTAG Device during the endovascular procedure.
Source facts
- Action
- The firm contact their consignee with a safety notice by letter on 09/25/2017. Gore is updating its Instructions for Use (IFU) to include the following new warnings and precautions: " If abnormal or inconsistent deployment line resistance is felt during deployment initiation, STOP deployment action immediately. If device remains constrained, remove device through the introducer sheath. If resistance is felt during removal through the sheath, stop and withdraw device and introducer sheath together. " If the device is in a partially deployed state and remains attached to the catheter, physicians should strongly consider conversion to immediate open surgical repair to avoid additional procedure time and potential harm from additional endovascular maneuvers.
- Initiated
- 2017-09-25
- Root cause
- Unknown/Undetermined by firm
- Terminated
- 2019-08-27
- Distribution
- Worldwide.
- Recall number
- Z-0048-2018
- Recall status
- Terminated
- CDRH record ID
- 158746
- FDA classified
- 2017-10-25
- Recall event number
- 78132